Teva Reaches Tentative $4.25 Billion Settlement Over Opioids
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The first checks could be cut in April. The money — from the nation’s three major pharmaceutical distributors and Johnson & Johnson — will be […]
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The 5-1 decision is a setback for those who are fighting to hold big drug makers accountable for the opioid epidemic.
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family […]
The payout to New York will take place over the next 17 years, and joins a $26 billion deal to settle the thousands of nationwide […]
The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment […]
Three drug distributors and Johnson & Johnson are also on the verge of a $26 billion deal to settle the thousands of nationwide lawsuits.
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.
The settlement agreement came just days before opening arguments in a sweeping trial of several defendants, including the company.
The settlement agreement came just days before opening arguments in a sweeping trial of several defendants, including the company.
The settlement agreement came just days before opening arguments in a sweeping trial of several defendants, including the company.
Copyright © 2024 | WordPress Theme by MH Themes